These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30032169)

  • 41. R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.
    Zhang JC; Li SX; Hashimoto K
    Pharmacol Biochem Behav; 2014 Jan; 116():137-41. PubMed ID: 24316345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.
    Yang B; Ren Q; Ma M; Chen QX; Hashimoto K
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.
    Jiang B; Wang F; Yang S; Fang P; Deng ZF; Xiao JL; Hu ZL; Chen JG
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
    Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
    Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of serum osteoprotegerin and receptor-activator of nuclear factor-κB ligand in metabolic bone disease of women after obesity surgery.
    Balsa JA; Lafuente C; Gómez-Martín JM; Galindo J; Peromingo R; García-Moreno F; Rodriguez-Velasco G; Martínez-Botas J; Gómez-Coronado D; Escobar-Morreale HF; Botella-Carretero JI
    J Bone Miner Metab; 2016 Nov; 34(6):655-661. PubMed ID: 26438320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FCPR16, a novel phosphodiesterase 4 inhibitor, produces an antidepressant-like effect in mice exposed to chronic unpredictable mild stress.
    Zhong Q; Yu H; Huang C; Zhong J; Wang H; Xu J; Cheng Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():62-75. PubMed ID: 30391306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model.
    Sun HL; Zhou ZQ; Zhang GF; Yang C; Wang XM; Shen JC; Hashimoto K; Yang JJ
    Transl Psychiatry; 2016 Feb; 6(2):e741. PubMed ID: 26905413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.
    Carreno FR; Donegan JJ; Boley AM; Shah A; DeGuzman M; Frazer A; Lodge DJ
    Mol Psychiatry; 2016 Sep; 21(9):1298-308. PubMed ID: 26619811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An update on ketamine and its two enantiomers as rapid-acting antidepressants.
    Zhang K; Hashimoto K
    Expert Rev Neurother; 2019 Jan; 19(1):83-92. PubMed ID: 30513009
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanisms underlying the rapid-acting antidepressant-like effects of neuropeptide VGF (non-acronymic) C-terminal peptide TLQP-62.
    Lv D; Chen Y; Shen M; Liu X; Zhang Y; Xu J; Wang C
    Neuropharmacology; 2018 Dec; 143():317-326. PubMed ID: 30291938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retigabine promotes ketamine's antidepressant effect in the forced swim test in male and female C57BL/6J mice.
    Qin Y; Li H; Zhang Y; Cao JL; Zhang W; Zhang H
    Pharmacol Biochem Behav; 2023 Sep; 230():173590. PubMed ID: 37336427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential Mechanisms Underlying Antidepressant Responses of Ketamine and Imipramine.
    Wei Z; Zhang K; Zhou Q; Huang M; Xu T; Dong J; Zheng Y; Cai X
    CNS Neurol Disord Drug Targets; 2017; 16(7):846-853. PubMed ID: 28462695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
    Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
    Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketamine's antidepressant action: beyond NMDA receptor inhibition.
    Hashimoto K
    Expert Opin Ther Targets; 2016 Nov; 20(11):1389-1392. PubMed ID: 27646666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine.
    Ide S; Ikekubo Y; Mishina M; Hashimoto K; Ikeda K
    J Pharmacol Sci; 2017 Nov; 135(3):138-140. PubMed ID: 29174627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VGF function in depression and antidepressant efficacy.
    Jiang C; Lin WJ; Sadahiro M; Labonté B; Menard C; Pfau ML; Tamminga CA; Turecki G; Nestler EJ; Russo SJ; Salton SR
    Mol Psychiatry; 2018 Jul; 23(7):1632-1642. PubMed ID: 29158577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions.
    Fuchikami M; Thomas A; Liu R; Wohleb ES; Land BB; DiLeone RJ; Aghajanian GK; Duman RS
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8106-11. PubMed ID: 26056286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysfunction of Serotonergic and Dopaminergic Neuronal Systems in the Antidepressant-Resistant Impairment of Social Behaviors Induced by Social Defeat Stress Exposure as Juveniles.
    Hasegawa S; Miyake Y; Yoshimi A; Mouri A; Hida H; Yamada K; Ozaki N; Nabeshima T; Noda Y
    Int J Neuropsychopharmacol; 2018 Sep; 21(9):837-846. PubMed ID: 29618006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus.
    LaGamma CT; Tang WW; Morgan AA; McGowan JC; Brachman RA; Denny CA
    Front Mol Neurosci; 2018; 11():404. PubMed ID: 30459554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.